[go: up one dir, main page]

DK2437762T3 - Kunstige tårer og terapeutiske anvendelser - Google Patents

Kunstige tårer og terapeutiske anvendelser

Info

Publication number
DK2437762T3
DK2437762T3 DK10724631.6T DK10724631T DK2437762T3 DK 2437762 T3 DK2437762 T3 DK 2437762T3 DK 10724631 T DK10724631 T DK 10724631T DK 2437762 T3 DK2437762 T3 DK 2437762T3
Authority
DK
Denmark
Prior art keywords
therapeutic uses
artificial tears
tears
artificial
therapeutic
Prior art date
Application number
DK10724631.6T
Other languages
English (en)
Inventor
Anuradha V Gore
Robert S Jordan
Kevin Krock
Chetan Pujara
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42312750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2437762(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK2437762T3 publication Critical patent/DK2437762T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
DK10724631.6T 2009-06-05 2010-06-03 Kunstige tårer og terapeutiske anvendelser DK2437762T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18433909P 2009-06-05 2009-06-05
PCT/US2010/037153 WO2010141648A2 (en) 2009-06-05 2010-06-03 Artificial tears and therapeutic uses

Publications (1)

Publication Number Publication Date
DK2437762T3 true DK2437762T3 (da) 2017-11-20

Family

ID=42312750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10724631.6T DK2437762T3 (da) 2009-06-05 2010-06-03 Kunstige tårer og terapeutiske anvendelser

Country Status (24)

Country Link
US (7) US8496976B2 (da)
EP (1) EP2437762B1 (da)
KR (1) KR101778316B1 (da)
CN (2) CN104906170A (da)
AU (1) AU2010256652B2 (da)
BR (1) BRPI1011710B8 (da)
CA (1) CA2764802A1 (da)
DK (1) DK2437762T3 (da)
ES (1) ES2646338T3 (da)
HK (1) HK1214943A1 (da)
HR (1) HRP20171691T1 (da)
HU (1) HUE034213T2 (da)
IL (1) IL216800A (da)
LT (1) LT2437762T (da)
MX (2) MX358504B (da)
MY (1) MY172185A (da)
NO (1) NO2437762T3 (da)
NZ (1) NZ596932A (da)
PL (1) PL2437762T3 (da)
PT (1) PT2437762T (da)
RU (1) RU2589837C2 (da)
SI (1) SI2437762T1 (da)
WO (1) WO2010141648A2 (da)
ZA (1) ZA201108979B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
HRP20171691T1 (hr) 2009-06-05 2017-12-15 Allergan, Inc. Umjetne suze i njihova upotreba u terapiji
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
SG11201403013VA (en) * 2011-12-07 2014-07-30 Allergan Inc Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) * 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
US10085960B2 (en) 2012-03-30 2018-10-02 Brien Holden Vision Institute Methods and compositions for reducing ocular discomfort
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions
WO2016029034A1 (en) 2014-08-20 2016-02-25 Silk Technologies, Ltd. Fibroin-derived protein composition
UA121399C2 (uk) * 2014-11-25 2020-05-25 Аллерган, Інк. Стабілізовані композиції для офтальмологічного застосування, які містять омега-3-кислоти
EP3362096B1 (en) 2015-10-14 2023-12-13 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
KR20190008210A (ko) 2016-04-08 2019-01-23 코넬 유니버시티 실크 유래 단백질을 이용한 상처 치료를 증가시키는 방법
WO2019005139A1 (en) * 2017-06-30 2019-01-03 Jenivision Inc. FORMULATIONS FOR HAIR GROWTH
US11478437B2 (en) 2016-07-05 2022-10-25 Jenivision Inc. Formulations for hair growth
PL3266446T3 (pl) * 2016-07-07 2019-05-31 Salvat Lab Sa Kompozycja oftalmiczna zawierająca olej rycynowy i trójgliceryd o średniej długości łańcucha
SG11201901137UA (en) 2016-08-12 2019-03-28 Silk Technologies Ltd Silk-derived protein for treating inflammation
EP3500344A4 (en) * 2016-08-19 2020-08-05 Akrivista, LLC METHODS OF DIAGNOSIS AND TREATMENT OF DRY EYE SYNDROME AND COMPOSITIONS FOR TREATMENT OF A HUMAN EYE
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
BR112020003276A2 (pt) 2017-08-18 2020-09-01 Akrivista, LLC métodos de diagnóstico e tratamento da síndrome do olho seco e composições para tratamento de um olho humano
KR20210038636A (ko) 2018-07-27 2021-04-07 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 눈 치료용 조성물 및 방법
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
BR112021000634A2 (pt) 2018-07-27 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
CN112888450A (zh) 2018-07-27 2021-06-01 强生外科视力公司 用于治疗眼睛的组合物和方法
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
KR20210009947A (ko) 2019-07-18 2021-01-27 윤영선 산소가 도입된 점안제, 및 그 제조방법
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824877A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
CN112823789B (zh) 2019-11-19 2024-05-10 强生外科视力公司 用于治疗眼睛的组合物和方法
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104814A (en) * 1980-01-25 1981-08-20 Kunihiro Okanoe Preparation of eye drop
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
DE3851152T2 (de) 1987-09-03 1995-01-26 Univ Georgia Cyclosporin-augenmittel.
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
FR2638089A1 (fr) * 1988-10-26 1990-04-27 Sandoz Sa Nouvelles compositions ophtalmiques a base d'une cyclosporine
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
WO1997024129A1 (en) 1995-12-27 1997-07-10 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition containing trehalose
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
GB0012597D0 (en) 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
US7027446B2 (en) 2001-07-18 2006-04-11 P-Cube Ltd. Method and apparatus for set intersection rule matching
JP4284491B2 (ja) 2002-07-16 2009-06-24 豊和工業株式会社 ピストン外形の加工データ生成装置
UY28126A1 (es) * 2002-12-24 2004-06-30 Alcon Inc Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular
US8992974B2 (en) * 2003-02-24 2015-03-31 Pharmaceuticals Productions, Inc. Transmucosal drug delivery system
US20060251685A1 (en) 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
WO2006007510A1 (en) 2004-07-01 2006-01-19 Schepens Eye Research Compositions and methods for treating eye disorders and conditions
EP1782801A4 (en) * 2004-08-27 2008-08-06 Senju Pharma Co EYEWASH FLUID FOR THERAPY DRY EYES
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CN100562340C (zh) * 2005-06-17 2009-11-25 中国科学院上海药物研究所 一种微乳型人工泪液
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008027341A2 (en) 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
CN101668511A (zh) * 2007-02-28 2010-03-10 阿西克斯医疗公司 正常化睑板腺分泌的方法和化合物
CN101554369B (zh) * 2008-05-12 2012-07-25 陈亚玲 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法
UA36915U (uk) * 2008-05-28 2008-11-10 Львівський Національний Медичний Університет Ім. Данила Галицького Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
HRP20171691T1 (hr) 2009-06-05 2017-12-15 Allergan, Inc. Umjetne suze i njihova upotreba u terapiji

Also Published As

Publication number Publication date
PL2437762T3 (pl) 2018-01-31
US20140141106A1 (en) 2014-05-22
US20240108677A1 (en) 2024-04-04
SI2437762T1 (en) 2018-02-28
US8496976B2 (en) 2013-07-30
US20130295206A1 (en) 2013-11-07
US8679554B2 (en) 2014-03-25
MX2011013007A (es) 2012-02-28
CN104906170A (zh) 2015-09-16
EP2437762B1 (en) 2017-08-09
US11045515B2 (en) 2021-06-29
HRP20171691T1 (hr) 2017-12-15
IL216800A (en) 2017-03-30
US9821020B2 (en) 2017-11-21
WO2010141648A3 (en) 2011-03-10
AU2010256652A1 (en) 2012-01-12
RU2011151468A (ru) 2013-07-20
HUE034213T2 (en) 2018-01-29
PT2437762T (pt) 2017-11-14
US20120201910A1 (en) 2012-08-09
LT2437762T (lt) 2017-11-27
BRPI1011710A2 (pt) 2016-03-22
ES2646338T3 (es) 2017-12-13
US20220008496A1 (en) 2022-01-13
NO2437762T3 (da) 2018-01-06
US20180264063A1 (en) 2018-09-20
CN102458430A (zh) 2012-05-16
CA2764802A1 (en) 2010-12-09
EP2437762A2 (en) 2012-04-11
ZA201108979B (en) 2012-08-29
KR20120046151A (ko) 2012-05-09
AU2010256652B2 (en) 2015-11-26
US20250082709A1 (en) 2025-03-13
HK1214943A1 (zh) 2016-08-12
KR101778316B1 (ko) 2017-09-13
WO2010141648A2 (en) 2010-12-09
BRPI1011710A8 (pt) 2019-11-05
NZ596932A (en) 2014-04-30
MX358504B (es) 2018-08-21
IL216800A0 (en) 2012-02-29
BRPI1011710B8 (pt) 2021-05-25
MY172185A (en) 2019-11-15
BRPI1011710B1 (pt) 2021-01-26
RU2589837C2 (ru) 2016-07-10

Similar Documents

Publication Publication Date Title
DK2437762T3 (da) Kunstige tårer og terapeutiske anvendelser
BRPI1008030A2 (pt) implantes lacrimais e métodos relacionados
NO2017033I1 (no) baricitinib og farmasøytisk akseptable salter derav
HRP20160737T1 (hr) Anti-her3-protutijela i njihove uporabe
BRPI0907890A2 (pt) Implantes lacrimais e métodos relacionados
BRPI0817082A2 (pt) Implantes lacrimais e métodos relacionados
DK3460056T3 (da) Terapeutiske nukleasesammensætninger og fremgangsmåder
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
EP2391307C0 (en) PENILE IMPLANT
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
DK3622815T3 (da) Gnavermodeller og terapeutiske molekyler
EP2515946A4 (en) NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES
FI20085334A0 (fi) Harjoitusmenetelmä ja -järjestelmä
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
EP2432410A4 (en) ARTIFICIAL INSEMINATION
BR112012010242A2 (pt) derivados de heteroarilpiperidina e heteroarilpiperazina
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme
EP2424476A4 (en) RETINA GRAFT
EP2404576A4 (en) MARKERS AND STENTS
DK2252688T3 (da) Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf
EP2767261C0 (en) Inflatable Penile Implant
DK2131682T3 (da) Autoklave og fremgangsmåde
DK2293846T3 (da) Depsipeptider og deres terapeutiske anvendelse
DK2307389T3 (da) Dibenzothiazepinderivat og anvendelser deraf
DK2310383T3 (da) 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf